Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma.
Kathrin OehlBart VrugtUlrich WagnerMichaela B KirschnerMayura MeerangWalter WederEmanuela Felley-BoscoBernd WollscheidKatrin BankovMelanie C DemesIsabelle OpitzPeter J WildPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Alterations in BAP1 in MPM were a negative predictor for response to chemotherapy and could possibly be used as a companion biomarker for treatment decision.